Explore more publications!
Switzerland Health Monitor
Submit Press Release

Switzerland Health Monitor Press Releases

Labels On
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
Info
Medela’s 2025 Global Breastfeeding & Lactation Symposium Series Unites Experts Across Three Continents to Advance Maternal and Infant Health
November 20, 2025

Medela’s 2025 Global Breastfeeding & Lactation Symposium Series Unites Experts Across Three Continents to Advance Maternal and Infant Health

Indeterminate GlobeNewswire, Inc.
Ayus Medical Group Launches Documentary on CBS Showcasing their Advances in Medical Relief
November 20, 2025

Ayus Medical Group Launches Documentary on CBS Showcasing their Advances in Medical Relief

Neutral EIN Presswire
Medical Flexible Packaging Market Size, Trends, Segments and Regional Data (NA/EU/APAC/LA/MEA) 2025-2035
November 19, 2025

Medical Flexible Packaging Market Size, Trends, Segments and Regional Data (NA/EU/APAC/LA/MEA) 2025-2035

Indeterminate GlobeNewswire, Inc.
Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz®, a First-in-Market Biosimilar to Simponi® (golimumab)
November 20, 2025

Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz®, a First-in-Market Biosimilar to Simponi® (golimumab)

Indeterminate GlobeNewswire, Inc.
Trust Stamp selected for Trust Village 2026 Programme in Switzerland
November 20, 2025

Trust Stamp selected for Trust Village 2026 Programme in Switzerland

Indeterminate GlobeNewswire, Inc.
Indonesia Joins the HealthAI Global Regulatory Network to Advance Responsible AI Adoption in Health
November 20, 2025

Indonesia Joins the HealthAI Global Regulatory Network to Advance Responsible AI Adoption in Health

Neutral EIN Presswire
ZIRCON-X Analysis: TLX250-CDx Impacts Clinical Decision Making for Almost Half of Patients with Indeterminate Renal Masses
November 19, 2025

ZIRCON-X Analysis: TLX250-CDx Impacts Clinical Decision Making for Almost Half of Patients with Indeterminate Renal Masses

Indeterminate GlobeNewswire, Inc.
PFAS In Non-Stick Cookware: Amir Alon Of Swiss Diamond Cookware Breaks It Down
November 19, 2025

PFAS In Non-Stick Cookware: Amir Alon Of Swiss Diamond Cookware Breaks It Down

Neutral EIN Presswire
Global and European Pharmaceutical Grade Sodium Chloride Market Outlook 2025 to 2035
November 19, 2025

Global and European Pharmaceutical Grade Sodium Chloride Market Outlook 2025 to 2035

Neutral EIN Presswire
Garret Biss Leads Veteran Wellness Programming at Oklahoma State University
November 18, 2025

Garret Biss Leads Veteran Wellness Programming at Oklahoma State University

Neutral EIN Presswire
Jointechlabs Expands in Europe With Swiss Registration and Appointment of Noted Physician to Scientific Board
November 18, 2025

Jointechlabs Expands in Europe With Swiss Registration and Appointment of Noted Physician to Scientific Board

Neutral EIN Presswire
Berberine API Market to Reach USD 973.13 Million by 2034, Driven by Expanding Healthcare Applications
November 17, 2025

Berberine API Market to Reach USD 973.13 Million by 2034, Driven by Expanding Healthcare Applications

Indeterminate GlobeNewswire, Inc.
Nxera Pharma Shares Video Interviews with Major Shareholders on Its Official YouTube Channel
November 17, 2025

Nxera Pharma Shares Video Interviews with Major Shareholders on Its Official YouTube Channel

Indeterminate GlobeNewswire, Inc.
Captain T Cell Closes Financing Round to Advance its Proprietary, Next-Generation TCR-T Pipeline Into the Clinic
November 17, 2025

Captain T Cell Closes Financing Round to Advance its Proprietary, Next-Generation TCR-T Pipeline Into the Clinic

Indeterminate GlobeNewswire, Inc.
ONWARD Medical Receives FDA 510(k) Clearance Expanding ARC-EX System Indication for Home Use
November 17, 2025

ONWARD Medical Receives FDA 510(k) Clearance Expanding ARC-EX System Indication for Home Use

Indeterminate GlobeNewswire, Inc.
FDA approves pembrolizumab with enfortumab vedotin-ejfv for muscle invasive bladder cancer
November 21, 2025

FDA approves pembrolizumab with enfortumab vedotin-ejfv for muscle invasive bladder cancer

Gov't Institution U.S. Food and Drug Administration
Owner: American Government

U.S. Food and Drug Administration

Gov't Institution
Owned By American Government through Department of Health and Human Services
Year Founded 1906
Website www.fda.gov
Domain Registration Year Indeterminate
Access Type open
Publication Location United States, Maryland, Silver Springs
Owner Country United States

We welcome your feedback!
If you have comments or corrections, let us know.

Demand for Infectious Disease Clinical Trials Market is forecasted to reach a value of US $19.82 billion by 2029
November 14, 2025

Demand for Infectious Disease Clinical Trials Market is forecasted to reach a value of US $19.82 billion by 2029

Neutral EIN Presswire
Building Trust in AI for Health at the HealthAI Global Governance Forum 2025
November 13, 2025

Building Trust in AI for Health at the HealthAI Global Governance Forum 2025

Neutral EIN Presswire
Quiet Lab Mouthpiece Launches: A Scientific Breakthrough in QuietLab Anti-Snoring Devices and Sleep Health Innovation
November 13, 2025

Quiet Lab Mouthpiece Launches: A Scientific Breakthrough in QuietLab Anti-Snoring Devices and Sleep Health Innovation

Indeterminate GlobeNewswire, Inc.
Numab Therapeutics and Kaken Pharmaceutical Announce Licensing and Co-development Agreement for Multispecific Antibody NM81 in Inflammatory Bowel Disease (IBD)
November 13, 2025

Numab Therapeutics and Kaken Pharmaceutical Announce Licensing and Co-development Agreement for Multispecific Antibody NM81 in Inflammatory Bowel Disease (IBD)

Indeterminate GlobeNewswire, Inc.
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions